Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics Anytime, Anywhere

Book Now and Start Streaming Today

Makoto Nakayama
Director, Antibody & Biologics Group at Kyowa Kirin
Speaker

Profile

Makoto Nakayama has over 15 years antibody technology and product development experiences. He has been engaged in the study of establishing and applying the REGULGENT^TM bispecific antibody technology. He currently works as Director of Antibody & Biologics Group in Research Core Function Laboratories at Kyowa Kirin Co., Ltd., leading antibody and biologics discovery and laboratory automation.

Agenda Sessions

Novel Bispecific Antibody Format with Reliable Productivity and Developability and Its Product Application
03:00
View Session

At this event

Prev

Next

David Baker, PhD

Professor of Biochemistry and Director, Institute for Protein Design

University of Washington